GREGORY REEVES: Open Payments
NPI 1396184487 · OGDEN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,505 in 82 payments from 15 companies in 2025. Trend: 2023 $895 · 2024 $1,200 · 2025 $1,505
Food & beverage: $1,405Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 21 | $339 |
| ABBVIE INC. | 18 | $257 |
| Janssen Biotech, Inc. | 7 | $234 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $150 |
| Biofrontera Inc. | 4 | $85 |
| Arcutis Biotherapeutics, Inc. | 4 | $75 |
| UCB, Inc. | 2 | $60 |
| Regeneron Healthcare Solutions, Inc. | 3 | $59 |
| Organon LLC | 5 | $57 |
| PFIZER INC. | 3 | $55 |
Products named: COSENTYX, TREMFYA, SKYRIZI, ILUMYA, RINVOQ, Zoryve, Bimzelx, LIBTAYO.
Industry payments across UT — which companies pay providers there.
